Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $247.40 | 30 | 59.0% |
| Food and Beverage | $172.16 | 3 | 41.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $224.66 | 28 | $0 (2018) |
| UroGen Pharma, Inc. | $108.68 | 1 | $0 (2023) |
| NeoTract Inc. | $63.48 | 2 | $0 (2017) |
| ABBVIE INC. | $20.25 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $108.68 | 1 | UroGen Pharma, Inc. ($108.68) |
| 2022 | $20.25 | 1 | ABBVIE INC. ($20.25) |
| 2021 | $2.49 | 1 | Travere Therapeutics, Inc. ($2.49) |
| 2018 | $224.66 | 28 | PFIZER INC. ($224.66) |
| 2017 | $63.48 | 2 | NeoTract Inc. ($63.48) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $108.68 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/21/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $20.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/13/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $2.49 | General |
| Category: Kidney Stones | ||||||
| 12/31/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $5.30 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $1.78 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $0.90 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $0.90 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $0.90 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $0.90 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2018 | PFIZER INC. | TOVIAZ (Drug) | Education | In-kind items and services | $2.08 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 05/15/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $0.90 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 161 | 173 | $60,810 | $7,301 |
| 2022 | 7 | 561 | 664 | $227,876 | $31,747 |
| 2021 | 16 | 1,003 | 1,314 | $692,104 | $74,377 |
| 2020 | 17 | 1,048 | 1,320 | $642,262 | $61,299 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 84 | $27,720 | $4,012 | 14.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 13 | 14 | $23,940 | $2,137 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 15 | $7,350 | $956.52 | 13.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 54 | 60 | $1,800 | $194.92 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 258 | 291 | $91,083 | $16,295 | 17.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 35 | 48 | $78,720 | $8,143 | 10.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 47 | $21,855 | $3,969 | 18.2% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 31 | 42 | $19,110 | $1,312 | 6.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $8,280 | $1,210 | 14.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 157 | 196 | $5,880 | $670.28 | 11.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 22 | 22 | $2,948 | $147.36 | 5.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 345 | 439 | $129,505 | $25,279 | 19.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 50 | 77 | $120,120 | $13,014 | 10.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 89 | $38,715 | $7,706 | 19.9% |
| 55700 | Biopsy of prostate gland | Office | 2021 | 27 | 27 | $42,120 | $5,146 | 12.2% |
| 52356 | Crushing of stone in urinary duct (ureter) with stent using an endoscope | Facility | 2021 | 13 | 15 | $87,730 | $4,580 | 5.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 44 | 44 | $18,920 | $3,447 | 18.2% |
| 76872 | Ultrasound of pelvic region through rectum | Office | 2021 | 27 | 27 | $35,910 | $2,770 | 7.7% |
| 51702 | Insertion of indwelling bladder catheter, simple | Office | 2021 | 13 | 62 | $51,088 | $2,733 | 5.4% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 14 | 19 | $90,400 | $2,163 | 2.4% |
| 51700 | Bladder irrigation and/or instillation | Office | 2021 | 40 | 60 | $25,800 | $1,811 | 7.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $8,060 | $1,666 | 20.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 22 | $7,260 | $1,202 | 16.6% |
| 81002 | Urinalysis, manual test | Office | 2021 | 239 | 324 | $9,396 | $1,115 | 11.9% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 22 | 22 | $17,182 | $981.64 | 5.7% |
About Dr. Jeffrey Derus, MD
Dr. Jeffrey Derus, MD is a Urology healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679564660.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Derus, MD has received a total of $419.56 in payments from pharmaceutical and medical device companies, with $108.68 received in 2023. These payments were reported across 33 transactions from 5 companies. The most common payment nature is "Education" ($247.40).
As a Medicare-enrolled provider, Derus has provided services to 2,773 Medicare beneficiaries, totaling 3,471 services with total Medicare billing of $174,723. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Milwaukee, WI
- Active Since 10/31/2005
- Last Updated 11/30/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1679564660
Products in Payments
- XTANDI (Drug) $222.58
- JELMYTO (Drug) $108.68
- Urolift - UL400 (Device) $63.48
- LUPRON DEPOT (Drug) $20.25
- Thiola (Drug) $2.49
- TOVIAZ (Drug) $2.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Milwaukee
Dr. Amy Guise, Md, MD
Urology — Payments: $121,206
Dr. Robert Oconnor, Md, MD
Urology — Payments: $32,733
Dr. Mark Waples, Md, MD
Urology — Payments: $15,342
Dr. Matthew Johnson, Md, MD
Urology — Payments: $10,827
Dr. Peter Leonovicz, Md, MD
Urology — Payments: $9,568
Graham Machen, M.d, M.D
Urology — Payments: $9,226